Boehringer Ingelheim -- Payments to Internal Medicine Physicians
This page provides a detailed breakdown of Boehringer Ingelheim's payments to Internal Medicine physicians, as reported in the CMS Open Payments (Sunshine Act) database. Understanding how a pharmaceutical company targets specific medical specialties reveals important patterns about their marketing strategies and physician relationships.
Payment Summary: Boehringer Ingelheim to Internal Medicine
- Total Payments to Internal Medicine Doctors: $1,399,252.57
- Number of Transactions: 166
- Number of Internal Medicine Doctors Paid: 20
- Average Payment Amount: $8,429.23
- Share of Boehringer Ingelheim's Total Spending: 24.7% of $5.7M
Why Does Boehringer Ingelheim Pay Internal Medicine Doctors?
Pharmaceutical companies make payments to physicians in specialties related to their product portfolio. Boehringer Ingelheim's payments to Internal Medicine specialists may include consulting fees for drug development advice, speaking engagements at medical conferences, clinical trial research funding, and meals during product education visits. The volume and types of payments to Internal Medicine doctors can indicate the importance of this specialty to Boehringer Ingelheim's business strategy.
Understanding the relationship between Boehringer Ingelheim and Internal Medicine physicians helps patients evaluate whether their doctor's prescribing patterns might be influenced by financial relationships with this company.
Payment Types: How Boehringer Ingelheim Pays Internal Medicine Doctors
The following table shows the breakdown of payment categories from Boehringer Ingelheim to Internal Medicine physicians:
| Payment Type | Total Amount | Transactions |
|---|---|---|
| Consulting Fees | $457,734.61 | 47 |
| Ownership Interest | $363,918.39 | 3 |
| Research Funding | $275,268.79 | 6 |
| Speaking & Education | $221,367.20 | 15 |
| general | $40,578.78 | 36 |
| Travel & Lodging | $34,575.29 | 11 |
| Food & Beverage | $5,809.51 | 48 |
Top Internal Medicine Doctors Paid by Boehringer Ingelheim
The following Internal Medicine physicians have received the largest total payments from Boehringer Ingelheim. Click on any physician to view their complete payment report.
| Physician | Total Received | Transactions |
|---|---|---|
| James Wilson | $141,036.77 | 1 |
| Matthew Walker | $115,567.26 | 1 |
| Steven Green | $107,314.36 | 1 |
| Heather Mitchell | $75,602.01 | 1 |
| Jeffrey Campbell | $73,132.26 | 1 |
| Catherine Morris | $57,722.51 | 1 |
| Christine Edwards | $42,880.98 | 1 |
| Heather Mitchell | $26,151.79 | 1 |
| Heather Mitchell | $24,318.07 | 1 |
| Michelle Scott | $23,276.09 | 1 |
| Stephanie King | $22,661.12 | 1 |
| Emily Thompson | $22,095.68 | 1 |
| Gregory Evans | $21,679.92 | 1 |
| Thomas Miller | $19,733.43 | 1 |
| Christine Edwards | $17,445.88 | 1 |
| Kevin Hill | $17,354.58 | 1 |
| Lisa Garcia | $16,557.62 | 1 |
| Brian Wright | $16,312.89 | 1 |
| Ashley Nelson | $15,991.24 | 1 |
| Heather Mitchell | $15,595.69 | 1 |
Recent Payments from Boehringer Ingelheim to Internal Medicine Physicians
| Doctor | Amount | Type | Drug/Device | Date |
|---|---|---|---|---|
| Angela Stewart | $5,562.65 | consulting | N/A | 2026-04-04 |
| Karen Harris | $172.62 | meals | N/A | 2026-03-31 |
| Richard Brown | $397.38 | general | N/A | 2026-03-30 |
| Rebecca Adams | $4,250.72 | speaking | N/A | 2026-03-28 |
| Michelle Scott | $23,276.09 | speaking | N/A | 2026-03-13 |
| Richard Brown | $15,439.89 | consulting | N/A | 2026-03-13 |
| Brian Wright | $7,943.44 | consulting | N/A | 2026-03-12 |
| Susan Taylor | $3,330.70 | consulting | N/A | 2026-03-09 |
| Eric Sanchez | $13,244.11 | consulting | N/A | 2026-02-25 |
| Christopher Clark | $3,951.01 | consulting | N/A | 2026-02-24 |
| Emily Thompson | $22,095.68 | speaking | N/A | 2026-02-24 |
| Donna Morgan | $2,826.95 | travel | N/A | 2026-02-22 |
| Heather Mitchell | $75,602.01 | research | N/A | 2026-02-21 |
| Joseph Carter | $1,564.50 | general | N/A | 2026-02-11 |
| Robert Johnson | $181.36 | meals | N/A | 2026-02-06 |
Frequently Asked Questions
How much does Boehringer Ingelheim pay Internal Medicine doctors?
According to CMS Open Payments data, Boehringer Ingelheim has made $1,399,252.57 in payments to Internal Medicine physicians across 166 transactions. The average payment is $8,429.23. These payments include consulting fees, speaking engagements, meals, research funding, and other transfers of value required to be reported under the Sunshine Act.
Which Internal Medicine doctors receive the most from Boehringer Ingelheim?
The top Internal Medicine physician receiving payments from Boehringer Ingelheim is James Wilson, with $141,036.77 across 1 transactions. View the full ranking table above for all Internal Medicine doctors paid by Boehringer Ingelheim.
Why does Boehringer Ingelheim target Internal Medicine specialists?
Pharmaceutical companies target medical specialties related to their product portfolio. Boehringer Ingelheim's payments to Internal Medicine doctors likely relate to drugs or devices used in internal medicine practice. These payments can include advisory board fees, clinical trial funding, and educational speaking engagements.
Should I be concerned if my Internal Medicine doctor takes money from Boehringer Ingelheim?
Payment from Boehringer Ingelheim to a Internal Medicine physician does not imply wrongdoing. Many payments represent legitimate professional activities like research and medical education. However, patients may want to ask their doctor about these relationships, especially if Boehringer Ingelheim products are being prescribed. Transparency helps patients have informed conversations with their physicians.
How does Boehringer Ingelheim's Internal Medicine spending compare to other pharma companies?
Boehringer Ingelheim has spent $1,399,252.57 on Internal Medicine physicians. To compare with other pharmaceutical companies, visit the Internal Medicine specialty page for a broader view of which companies spend the most on this medical specialty.
Related Reports
Data from CMS Open Payments (Sunshine Act). Payment does not imply wrongdoing. AI analysis is not medical or legal advice.